Philippe Vanparys

2.5k total citations
33 papers, 1.3k citations indexed

About

Philippe Vanparys is a scholar working on Cancer Research, Molecular Biology and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Philippe Vanparys has authored 33 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cancer Research, 15 papers in Molecular Biology and 10 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Philippe Vanparys's work include Carcinogens and Genotoxicity Assessment (16 papers), Effects and risks of endocrine disrupting chemicals (10 papers) and Animal testing and alternatives (9 papers). Philippe Vanparys is often cited by papers focused on Carcinogens and Genotoxicity Assessment (16 papers), Effects and risks of endocrine disrupting chemicals (10 papers) and Animal testing and alternatives (9 papers). Philippe Vanparys collaborates with scholars based in Belgium, United States and Italy. Philippe Vanparys's co-authors include David Kirkland, D. Gatehouse, Lesley Reeve, Raffaella Corvi, Sebastian Hoffmann, Stefan Pfuhler, Jan van Benthem, Jacky Van Gompel, Luc Verschaeve and Thomas Härtung and has published in prestigious journals such as Toxicological Sciences, Toxicology and Toxicology Letters.

In The Last Decade

Philippe Vanparys

32 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philippe Vanparys Belgium	22	502	471	390	313	209	33	1.3k
Freddy Van Goethem Belgium	17	296 0.6×	276 0.6×	203 0.5×	191 0.6×	127 0.6×	31	939
Johannes J.M. van de Sandt Netherlands	24	182 0.4×	286 0.6×	441 1.1×	455 1.5×	217 1.0×	42	1.7k
Carl Westmoreland United Kingdom	18	176 0.4×	256 0.5×	265 0.7×	228 0.7×	107 0.5×	37	1.1k
Willi Suter Switzerland	23	553 1.1×	534 1.1×	293 0.8×	117 0.4×	217 1.0×	63	1.4k
Björn Ekwall Sweden	22	253 0.5×	217 0.5×	447 1.1×	607 1.9×	163 0.8×	41	1.3k
Roland Buesen Germany	20	151 0.3×	599 1.3×	339 0.9×	88 0.3×	101 0.5×	45	1.2k
Robert A. LeBœuf United States	22	500 1.0×	568 1.2×	312 0.8×	114 0.4×	120 0.6×	43	1.2k
Mike O’Donovan United Kingdom	14	476 0.9×	352 0.7×	271 0.7×	90 0.3×	181 0.9×	24	946
Azeddine Elhajouji Switzerland	25	1.3k 2.7×	1.0k 2.2×	676 1.7×	138 0.4×	516 2.5×	47	2.2k
Susanne Brendler‐Schwaab Germany	13	493 1.0×	359 0.8×	286 0.7×	169 0.5×	242 1.2×	23	1.1k

Countries citing papers authored by Philippe Vanparys

Since Specialization

Citations

This map shows the geographic impact of Philippe Vanparys's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Vanparys with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Vanparys more than expected).

Fields of papers citing papers by Philippe Vanparys

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Vanparys. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Vanparys. The network helps show where Philippe Vanparys may publish in the future.

Co-authorship network of co-authors of Philippe Vanparys

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Vanparys. A scholar is included among the top collaborators of Philippe Vanparys based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Vanparys. Philippe Vanparys is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ates, Gamze, Birgit Mertens, Luc Verschaeve, et al.. (2018). A novel genotoxin-specific qPCR array based on the metabolically competent human HepaRG™ cell line as a rapid and reliable tool for improved in vitro hazard assessment. Archives of Toxicology. 92(4). 1593–1608. 24 indexed citations

Wever, Bart De, Alan M. Goldberg, Chantra Eskes, et al.. (2015). “Open Source”–Based Engineered Human Tissue Models: A New Gold Standard for Nonanimal Testing Through Openness, Transparency, and Collaboration, Promoted by the ALEXANDRA Association. 1(1). 5–9. 10 indexed citations

Willems, Maxime, Els Adriaens, Michelle Plusquin, et al.. (2015). An Adult Stem Cell Proliferation Assay in the Flatworm Model Macrostomum lignano to Predict the Carcinogenicity of Compounds. Document Server@UHasselt (UHasselt). 1(3). 213–219. 2 indexed citations

Kirkland, David, Errol Zeiger, Federica Madia, et al.. (2014). Can in vitro mammalian cell genotoxicity test results be used to complement positive results in the Ames test and help predict carcinogenic or in vivo genotoxic activity? I. Reports of individual databases presented at an EURL ECVAM Workshop. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 775-776. 55–68. 50 indexed citations

Verstraelen, Sandra, An Jacobs, Bart De Wever, & Philippe Vanparys. (2013). Improvement of the Bovine Corneal Opacity and Permeability (BCOP) assay as an in vitro alternative to the Draize rabbit eye irritation test. Toxicology in Vitro. 27(4). 1298–1311. 31 indexed citations

Corvi, Raffaella, Marilyn J. Aardema, Laura Gribaldo, et al.. (2011). ECVAM prevalidation study on in vitro cell transformation assays: General outline and conclusions of the study. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 744(1). 12–19. 51 indexed citations

Vanparys, Philippe. (2011). ECVAM prevalidation of three cell transformation assays. ALTEX. 28(1). 56–59. 23 indexed citations

Kirkland, David, Lesley Reeve, D. Gatehouse, & Philippe Vanparys. (2011). A core in vitro genotoxicity battery comprising the Ames test plus the in vitro micronucleus test is sufficient to detect rodent carcinogens and in vivo genotoxins. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 721(1). 27–73. 176 indexed citations

Verstraelen, Sandra, Erik W. Hansen, Freddy Van Goethem, & Philippe Vanparys. (2011). Development of a new opacitometer for the bovine corneal opacity and permeability (BCOP) assay. Toxicology Letters. 205. S179–S179.

10.

Henkens, Tom, Sarah Snykers, Mathieu Vinken, et al.. (2010). Preservation of hepatocellular functionality in cultures of primary rat hepatocytes upon exposure to 4-Me2N-BAVAH, a hydroxamate-based HDAC-inhibitor. Toxicology in Vitro. 25(1). 100–109. 2 indexed citations

11.

Pfuhler, Stefan, David Kirkland, Peter Kasper, et al.. (2009). Reduction of use of animals in regulatory genotoxicity testing: Identification and implementation opportunities—Report from an ECVAM workshop. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 680(1-2). 31–42. 76 indexed citations

12.

Peters, Annelieke K., et al.. (2008). Evaluation of the Embryotoxic Potency of Compounds in a Newly Revised High Throughput Embryonic Stem Cell Test. Toxicological Sciences. 105(2). 342–350. 37 indexed citations

13.

Mesens, Natalie, et al.. (2008). A 96-well flow cytometric screening assay for detecting in vitro phospholipidosis-induction in the drug discovery phase. Toxicology in Vitro. 23(2). 217–226. 24 indexed citations

14.

Smedt, Ann De, Margino Steemans, Marlies De Boeck, et al.. (2008). Optimisation of the cell cultivation methods in the embryonic stem cell test results in an increased differentiation potential of the cells into strong beating myocard cells. Toxicology in Vitro. 22(7). 1789–1796. 33 indexed citations

15.

Chapin, Robert E., Karen Augustine‐Rauch, Bruce Beyer, et al.. (2008). State of the art in developmental toxicity screening methods and a way forward: a meeting report addressing embryonic stem cells, whole embryo culture, and zebrafish. Birth Defects Research Part B Developmental and Reproductive Toxicology. 83(4). 446–456. 49 indexed citations

16.

Peters, Annelieke K., et al.. (2008). Automated analysis of contractility in the embryonic stem cell test, a novel approach to assess embryotoxicity. Toxicology in Vitro. 22(8). 1948–1956. 21 indexed citations

17.

Boeck, Marlies De, Freddy Van Goethem, Ann De Smedt, et al.. (2005). Flow cytometric analysis of micronucleated reticulocytes: Time- and dose-dependent response of known mutagens in mice, using multiple blood sampling. Environmental and Molecular Mutagenesis. 46(1). 30–42. 24 indexed citations

18.

Goethem, Freddy Van, Nathalie Alépée, Frank Straube, et al.. (2005). Prevalidation of a new in vitro reconstituted human cornea model to assess the eye irritating potential of chemicals. Toxicology in Vitro. 20(1). 1–17. 94 indexed citations

19.

Vanparys, Philippe, et al.. (1992). Sampling times in micronucleus testing. Mutation Research Letters. 282(3). 191–196. 36 indexed citations

20.

Vanparys, Philippe, et al.. (1990). The micronucleus assay as a test for the detection of aneugenic activity. Mutation Research Letters. 244(2). 95–103. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact